Conference Call Focused on Financial Insights
STERIS plc, recognized for its contributions in enhancing patient care globally, has exciting news on the horizon. A conference call is scheduled to take place to discuss the financial results for the fourth quarter and the entire fiscal year, promising insights into the dynamic operations of the company. This event will occur at 9:00 a.m. ET on May 15. Stakeholders and interested parties are encouraged to participate in this call to gain a clearer understanding of the company’s performance and future directions.
How to Participate in the Conference Call
For those wishing to join, the conference call will be accessible both online and via phone. The online broadcast will be hosted on the company's official investor relations site. Alternatively, participants can dial in directly by calling either 1-833-535-2199 if located in the United States or 1-412-902-6776 for international access. Once connected, simply request to join the STERIS plc conference call.
Release of Financial Results
In advance of the call, STERIS will release a detailed press statement outlining its financial results after the market closes on the previous day. This proactive disclosure will set the stage for the call, allowing for informed discussions regarding the company’s performance metrics.
Replay for Interested Parties
Recognizing that not everyone may be able to attend the live call, STERIS has arranged for a replay of the conference. This will start at 12:00 p.m. ET on May 15 and will be available either through the company's website or via telephone. For those who wish to access the replay, simply dial 1-877-344-7529 in the U.S. or 1-412-317-0088 internationally, using the access code 5194825.
About STERIS plc
STERIS plc stands as a pillar in the healthcare industry, specializing in solutions that emphasize infection prevention. Their mission is clear: to help customers create a healthier and safer world through innovative products and services tailored for the healthcare and life sciences sectors. With a commitment to excellence, STERIS fosters environments where patient care can thrive.
Company Leadership
Communication with investors and the public is crucial for STERIS. Julie Winter, serving as the Vice President of Investor Relations and Corporate Communications, is the key contact for any inquiries related to the upcoming call. She can be reached directly at her email or by phone for further information.
Anticipation Ahead of Key Financial Updates
The forthcoming conference call is expected to engage stakeholders, as many will be keen to learn how STERIS has navigated through the recent challenges in the healthcare landscape. With a spotlight on growth and investment strategies, the management team will undoubtedly address critical areas that affect the company's trajectory in the coming year.
Investing in the Future
Investors will be particularly focused on how STERIS is planning to allocate resources moving forward. The information shared during this call will be pivotal for understanding the operational shifts that may arise due to evolving market trends and consumer needs within the industry.
Frequently Asked Questions
What is the purpose of the conference call?
The conference call aims to discuss STERIS's fourth quarter and full year financial results, providing insights into the company’s performance.
When is the conference call scheduled?
The conference call will take place on May 15 at 9:00 a.m. ET.
How can I participate in the call?
Participants can join the call online or via phone. The call-in numbers are available and can also be accessed through the STERIS website.
Will there be a replay available?
Yes, a replay of the conference call will be available starting at 12:00 p.m. ET on May 15.
Who can I contact for more information?
Julie Winter is the main contact for inquiries related to the conference call and can be reached via email or phone.
